The ASCP Annual Meeting will be held from May 29 - June 2, 2017 in Miami, FL, at the Loews Miami Beach Hotel. The meeting will include representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information.
A Steering Committee chaired by Drs. Marlene Freeman and John W. Newcomer with representation of the sectors that are part of the ASCP community lead the direction of the meeting. Representatives from the FDA, EMA, NIMH, NIDA, NIAAA, and academia comprise the 2017 Steering Committee. A Program Committee under the leadership of Drs. Holly Swartz and Alan Gelenberg are responsible for review of all program submissions.
ASCP Members do receive a discount on the annual meeting registration. If interested in becoming a member, you will have the opportunity to apply for membership during the registration process.
* All registration types will be verified upon submission of your registration and are subject to change if incorrectly selected.
REGISTRATION CANCELLATION POLICY Meeting registration refunds in writing will be accepted until April 28, 2017. A $75 cancellation fee will be assessed. Refunds are processed within 30 days after receiving a written request. No refunds will be given after April 28, 2017.
You must login to access 2016 Annual Meeting information.